Results 261 to 270 of about 63,889 (276)

Early Trough Levels and Antibodies to Infliximab Predict Safety and Success of Reinitiation of Infliximab Therapy

Clinical Gastroenterology and Hepatology, 2014
Severine Vermeire, Ann Gils, Niels Vande Casteele   +2 more
exaly  

Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis

Rheumatology, 2011
Laura Nuño-Nuño, Alejandro Balsa, Chamaida Plasencia-Rodríguez   +2 more
exaly  

Antibodies to Infliximab Are Associated with Lower Infliximab Levels and Increased Likelihood of Surgery in Pediatric IBD

Inflammatory Bowel Diseases, 2015
Emil Chuang, Sharat Singh
exaly  

Infliximab

Reactions Weekly, 2008
openaire   +2 more sources

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

Lancet, The, 2002
Stephen Hanauer, Brian Feagan, Daniel Rachmilewitz   +2 more
exaly  

Infliximab for the treatment of active scleritis

Canadian Journal of Ophthalmology, 2009
H Nida Sen, Grace A Levy-Clarke
exaly  

Long-term Infliximab Maintenance Therapy for Ulcerative Colitis: The ACT-1 and -2 Extension Studies

Inflammatory Bowel Diseases, 2012
Bruce Sands, Daniel Rachmilewitz
exaly  

Infliximab

Reactions Weekly, 2015
openaire   +2 more sources

Pattern of infliximab utilization in rheumatoid arthritis patients at an academic medical center

Arthritis and Rheumatism, 2005
Michael Weinblatt, Lori Chibnik, Sandeep Agarwal   +2 more
exaly  

Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease

Clinical Gastroenterology and Hepatology, 2004
Stephen Hanauer, Mohan Bala, Suzanne Travers   +2 more
exaly